2021
Public health risks associated with methadone in Iran: A systematic review and meta-analysis
Rostam-Abadi Y, Gholami J, Noroozi A, Ansari M, Baheshmat S, Hamzehzadeh M, Ghadirzadeh M, Vahdani B, Ekhtiari H, Mojtabai R, Rahimi-Movaghar A. Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal Of Drug Policy 2021, 100: 103529. PMID: 34826790, DOI: 10.1016/j.drugpo.2021.103529.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentNon-prescribed useMethadone useSystematic reviewGeneral populationPositive health outcomesUse disorderFemale general populationSystematic review of studiesSixty-five studiesRandom-effects modelLegal Medicine OrganizationMethadone maintenance treatment programsPublic health concernHealth outcomesSubstance-related deathsReview of studiesPooled proportionCases of acute poisoningMaintenance treatmentMedicine organizationsDrug treatment centersIranian databasesAdverse outcomesPrescription opioidsHIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis
Gholami J, Rostam‐Abadi Y, Rahimi Y, Fotouhi A, Amin‐Esmaeili M, Rahimi‐Movaghar A. HIV prevalence among non‐injecting people who use drugs and related factors in Iran: A systematic review and meta‐analysis. Drug And Alcohol Review 2021, 41: 666-676. PMID: 34783411, DOI: 10.1111/dar.13407.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus prevalenceHuman immunodeficiency virusOdds of HIV infectionHIV infectionSystematic reviewPrevalence of human immunodeficiency virusPrevalence of HIV infectionReduce HIV prevalenceRandom-effects modelCitation trackingHIV prevalenceImmunodeficiency virusNo significant differenceHarm reductionPWUDGeneral populationUnpublished studiesGender subgroupsComprehensive searchNational databaseMeta-analysisSignificant differencePrevalencePreventive measuresInfectionEvidence for an increase in cannabis use in Iran – A systematic review and trend analysis
Rostam-Abadi Y, Gholami J, Amin-Esmaeili M, Baheshmat S, Hamzehzadeh M, Rafiemanesh H, Nasserbakht M, Ghalichi L, Safarcherati A, Taremian F, Mojtabai R, Rahimi-Movaghar A. Evidence for an increase in cannabis use in Iran – A systematic review and trend analysis. PLOS ONE 2021, 16: e0256563. PMID: 34460847, PMCID: PMC8404985, DOI: 10.1371/journal.pone.0256563.Peer-Reviewed Original ResearchConceptsCannabis use disorderCannabis useUse disorderPrevalence of cannabis use disorderTrends of cannabis usePrevalence of cannabis useGeneral populationPrevalence estimatesHigh-risk groupIranian general populationRandom-effects modelPooled prevalence estimatePooled prevalenceYouth groupsCannabisA systematic reviewSex subgroupsIllicit substancesIranian databasesPrevalenceSystematic reviewNational studyFemale university studentsDisordersMale
2020
Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis
Rostam‐Abadi Y, Gholami J, Amin‐Esmaeili M, Safarcherati A, Mojtabai R, Ghadirzadeh M, Rahimi H, Rahimi‐Movaghar A. Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis. Addiction 2020, 115: 2213-2242. PMID: 32196801, DOI: 10.1111/add.15059.Peer-Reviewed Original ResearchConceptsPooled estimatesSystematic reviewConsistent with Preferred Reporting ItemsPrevalence of non-prescribed useIranian general populationPreferred Reporting ItemsPublic health challengeSystematically review studiesRandom-effects modelPrevalence of tramadol useMisuse of tramadolPublic health consequencesReporting ItemsHealth challengesPrescription analgesicsGeneral populationHealth consequencesHeterogeneous reportingFemale university studentsTramadol-related deathsMeta-analysisTramadol useSubgroups of malesNon-prescribed usePooled percentage